Stem cell therapy company Amniotics raises SEK 60 million before deduction of transaction costs, in First North IPO to advance lead candidate PulmoStem(TM) into clinic

Novel source of stem cells in full-term amniotic fluid provides basis for broad pipeline LUND, Sweden, July 12, 2021 /PRNewswire/ -- Amniotics AB (publ) ("Amniotics" or the "Company"), a stem cell therapy company has raisedSEK60 million through its recent listing on Nasdaq First North Growth Mar...